The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Home
>
California
>
Los Angeles
>
Grifols Biologicals Inc

Grifols Biologicals Inc

  • Contact Person: Edna Shahvosian
  • Contact Phone: 323-227-7560
  • Contact Email: Edna.Shahvosian@grifols.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Manufacturer of Goods
  • Industries Served: Biological Product (except Diagnostic) Manufacturing
  • Product Areas: SCREWS, BOLTS, NUTS AND WASHERS, NAILS, MACHINE KEYS, AND PINS, FASTENING DEVICES, HARDWARE, COMMERCIAL, HARDWARE

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $9,799 - Monday the 17th of October 2011
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    ALBUMIN
  • $9,609 - Friday the 2nd of March 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    ALBUMIN
  • $94,906 - Thursday the 22nd of March 2012
    Veterans Affairs Department
    573-NF/SG VETERANS HEALTH SYSTEM
    PHARMACY SUPPLIES/DRUGS
  • $9,048 - Friday the 6th of July 2012
    Veterans Affairs Department
    546-MIAMI
    CRITICAL FUNCTIONS/FLEBOGAMA PATIENT REQUIRED
  • $8,797 - Tuesday the 24th of July 2012
    Veterans Affairs Department
    573-NF/SG VETERANS HEALTH SYSTEM
    EMERGENCY DRUG ORDER
  • $8,271 - Monday the 2nd of July 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    ALBUMIN
  • $8,094 - Thursday the 5th of January 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    ALBUMIN
  • $8,009 - Wednesday the 4th of April 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    ALBUMIN
  • $78,711 - Tuesday the 11th of September 2012
    Veterans Affairs Department
    673-TAMPA
    MEDICAL DRUG
  • $77,754 - Friday the 29th of June 2012
    Veterans Affairs Department
    549-DALLAS
    EMERGENCY DRUG PROCUREMENT

© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.